Search
for
Sort by
Research 181–210 of 1000+
- Commonly encountered symptoms and their management in patients with cirrhosis
- Hair Loss, Diagnosis, and Treatment Planning
- Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- Androgen deprivation therapy and hormonal status in men with COVID-19
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Post COVID Alopecia in the Indian Subcontinent - A Harbinger of Disease Severity
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- 072 Covid-19 and male androgenetic alopecia: Systematic investigation of a potential epidemiological and genetic association
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Is COVID-19 Gender-sensitive?
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2